Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Retrospective Chart Review of Patients Undergoing Ketamine Infusions at the Canadian Rapid Treatment Center of Excellence


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04209296

Organisation Name: Brain and Cognition Discovery Foundation

Overal Status: Enrolling by invitation

Start Date: December 3, 2019

Last Update: December 24, 2020

Lead Sponsor: Brain and Cognition Discovery Foundation

Brief Summary: The Canadian Rapid Treatment Center of Excellence (CRTCE) is a healthcare facility principally focused on providing best practices of intravenous ketamine treatment to adult patients suffering from mental health conditions. The center focuses specifically on treating individuals suffering from major depression disorder, bipolar disorder, post-traumatic stress disorder and obsessive compulsive disorder as their primary diagnosis. Herein, this retrospective analysis aims to look at past data in order to further develop our understanding of ketamine in the use of psychiatry.

Conditions:
  • Major Depressive Disorder
  • Bipolar Disorder
  • Obsessive-Compulsive Disorder
  • Post Traumatic Stress Disorder


Total execution time in seconds: 0.21423602104187